Steven Wolin sold $354k of OSCR
Chief Operating Officer at Oscar Health, Inc.. 19,580 shares at an average of $18.08, traded Dec 2, 2024, filed Dec 3, 2024.
Score components
- +20RoleCOO
- +15Trade size$354k at market
- +5Share of holdings soldSold 16% of holdings
- +15Cluster7 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001562180-24-008104, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 1, 2024 | MOption exercise Class A Common Stock | +6,033 | - | - | 89,747 | Dec 3, 2024 |
| Dec 1, 2024 | MOption exercise Class A Common Stock | +1,483 | - | - | 91,230 | Dec 3, 2024 |
| Dec 1, 2024 | MOption exercise Class A Common Stock | +1,897 | - | - | 93,127 | Dec 3, 2024 |
| Dec 1, 2024 | MOption exercise Class A Common Stock | +24,671 | - | - | 117,798 | Dec 3, 2024 |
| Dec 1, 2024 | MOption exercise Class A Common Stock | +2,920 | - | - | 120,718 | Dec 3, 2024 |
| Dec 1, 2024 | MOption exercise Class A Common Stock | +1,460 | - | - | 122,178 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -19,227 | $18.07 | $347k | 102,951 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -353 | $18.48 | $6,523 | 102,598 | Dec 3, 2024 |
| Dec 1, 2024 | MOption exercise Restricted Stock Unitsderivative | -6,033 | $0.00 | $0 | 6,034 | Dec 3, 2024 |
| Dec 1, 2024 | MOption exercise Restricted Stock Unitsderivative | -1,483 | $0.00 | $0 | 1,483 | Dec 3, 2024 |
| Dec 1, 2024 | MOption exercise Restricted Stock Unitsderivative | -1,897 | $0.00 | $0 | 1,897 | Dec 3, 2024 |
| Dec 1, 2024 | MOption exercise Restricted Stock Unitsderivative | -24,671 | $0.00 | $0 | 123,356 | Dec 3, 2024 |
| Dec 1, 2024 | MOption exercise Restricted Stock Unitsderivative | -2,920 | $0.00 | $0 | 26,282 | Dec 3, 2024 |
| Dec 1, 2024 | MOption exercise Restricted Stock Unitsderivative | -1,460 | $0.00 | $0 | 13,141 | Dec 3, 2024 |
Related signals
Other insiders at Oscar Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | Oscar Health, Inc. | Vanessa Ames Wittman director | $806k 25,000 shares | -18% | |
| 15Weak | Oscar Health, Inc. | Victoria Baltrus Chief Accounting Officer | $30k 958 shares | -0% | |
| 41Moderate | Oscar Health, Inc. | Richard Scott Blackley Chief Financial Officer | $908k 28,869 shares | -3% | |
| 30Weak | Oscar Health, Inc. | Janet Liang President, Oscar Insurance | $326k 10,360 shares | -4% | |
| 24Weak | Oscar Health, Inc. | Adam McAnaney Chief Legal Officer | $286k 9,092 shares | -4% | |
| 35Weak | Oscar Health, Inc. | Mario Schlosser President of Technology & CTO | $988k 31,422 shares | -7% | |
| 40Moderate | OSCRsell Oscar Health, Inc. | Mario Schlosser President of Technology & CTO | $7.3M 395,000 shares | -44% | |
| 41Moderate | OSCRsell Oscar Health, Inc. | Elbert O. Robinson Jr. director | $411k 25,000 shares | -28% | |
| 20Weak | Oscar Health, Inc. | Richard Scott Blackley Chief Financial Officer | $484k 29,939 shares | -3% | |
| 8Weak | Oscar Health, Inc. | Alessandrea C. Quane EVP, Chief Insurance Officer | $271k 16,793 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.